Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Endo Health says FDA agreed to review its application for the testosterone injection Aveed
Yahoo/AP
Friday, September 6, 2013 - 8:57am
tags:
FDA, Endo Health Solutions, testosterone, Aveed
Novartis announces global licensing, research collaboration with Regenerex
Yahoo/Fly on the Wall
Friday, September 6, 2013 - 8:21am
tags:
Novartis, Regeneron, R&D, liscensing
Pfizer Looks Good Despite Disappointing Eliquis Sales
Seeking Alpha
Friday, September 6, 2013 - 8:20am
tags:
Pfizer, Merck, Bristol-Myers Squibb, Eliquis, DVT, bloodthinners
4 Healthcare Stock Stories Making Sector Headlines Thursday
Wall St. Cheat Sheet
Thursday, September 5, 2013 - 6:54pm
tags:
Celgene, MM-003, AlaicBronchial Thermoplasty, Boston Scientific, Aveed, Endo Health Solutions, Neuralstem
Theravance says lung disease drug TD-4208 succeeded in a midstage clinical trial
Yahoo/AP
Thursday, September 5, 2013 - 6:51pm
tags:
Theravance, TD-4208, COPD
5 Pharmas Spending the Most on Advertising to Physicians in Print Media
Motley Fool
Thursday, September 5, 2013 - 6:50pm
tags:
JNJ, Forest Labs, Pfizer, Novartis, Ironwood Pharmaceuticals
MacroGenics trumpets cancer immunotherapies in $60M IPO pitch
Fierce Biotech
Thursday, September 5, 2013 - 8:56am
tags:
Macrogenics, cancer immunotherapy, IPOs
Can GlaxoSmithKline Get Past Recent Headlines?
Wall St. Cheat Sheet
Thursday, September 5, 2013 - 8:51am
tags:
GSK
Merck Hopes Alzheimer's Drug Fares Better Than Competitors
TheStreet.com
Thursday, September 5, 2013 - 8:50am
tags:
Merck, Alzheimer's disease, Pfizer, Eli Lilly, JNJ, bapineuzumab, solanezumab, BACE inhibitors, MK-8931
False Claims, Off-Label Prescribing And Doctors, Part Two
Pharmalot
Thursday, September 5, 2013 - 8:45am
tags:
off-label, physicians, False Claims Act
Celgene says phase III study of pomalidomide combo met primary endpoint
Yahoo/Fly on the Wall
Thursday, September 5, 2013 - 8:26am
tags:
Celgene, pomalidomide, Multiple Myeloma
Another Prize Slips Through Novo's Hands As Big PBM Looks Elsewhere
Seeking Alpha
Thursday, September 5, 2013 - 8:24am
tags:
Novo Nordisk, diabetes
Amarin Regains Ahead Of Vital Q4 Catalysts
Seeking Alpha
Thursday, September 5, 2013 - 8:23am
tags:
Amarin, Vascepa
Sanofi will sell Pozen cardiovascular drugs in US
Yahoo/AP
Thursday, September 5, 2013 - 8:20am
tags:
Sanofi, Pozen, cardiovascular disease, PA8140, PA32540
Karo Bio Jumps After Reaching Milestone Payment: Stockholm Mover
Bloomberg
Thursday, September 5, 2013 - 8:17am
tags:
Karo Bio, Pfizer
GSK’s MAGE-A3 Cancer Immunotherapeutic Phase 3 Study in Melanoma Misses First Co-Primary Endpoint
Yahoo
Thursday, September 5, 2013 - 8:15am
tags:
GSK, melanoma, Agenus
Three Ways To Understand GSK's China Scandal
Forbes
Thursday, September 5, 2013 - 8:13am
tags:
GSK, China
Patent ruling on Lilly's Alimta lung-cancer drug expected in 2014
Reuters
Wednesday, September 4, 2013 - 5:37pm
tags:
Eli Lilly, Alimta, lung cancer, patents
Japan's Otsuka to buy Astex Pharma for about $900 million
Reuters
Wednesday, September 4, 2013 - 5:33pm
tags:
Japan, M&A, Otsuka, Astex
Pursuing Alzheimer's, iPierian grabs $30M and spins off orphan drug biotech
Fierce Biotech
Wednesday, September 4, 2013 - 1:16pm
tags:
orphan drugs, iPierian, Alzheimer's disease, stem cells

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.